Package 42667-5511-1

{"route": ["NASAL"], "spl_id": "3ab4a3a7-6d2d-ac70-e063-6394a90afb84", "openfda": {"nui": ["N0000175824", "N0000000146", "M0001109"], "unii": ["3XMK78S47O"], "rxcui": ["1596782", "1596784"], "spl_set_id": ["dea6bed1-eaca-11e3-ac10-0800200c9a66"], "pharm_class_cs": ["Androstanes [CS]"], "pharm_class_epc": ["Androgen [EPC]"], "pharm_class_moa": ["Androgen Receptor Agonists [MoA]"], "manufacturer_name": ["Acerus Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 APPLICATOR in 1 BOX (42667-5511-1)  / 11 g in 1 APPLICATOR", "package_ndc": "42667-5511-1", "marketing_start_date": "20200508"}], "brand_name": "Natesto nasal gel", "product_id": "42667-5511_3ab4a3a7-6d2d-ac70-e063-6394a90afb84", "dosage_form": "GEL, METERED", "pharm_class": ["Androgen Receptor Agonists [MoA]", "Androgen [EPC]", "Androstanes [CS]"], "product_ndc": "42667-5511", "dea_schedule": "CIII", "generic_name": "testosterone", "labeler_name": "Acerus Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Natesto", "brand_name_suffix": "nasal gel", "active_ingredients": [{"name": "TESTOSTERONE", "strength": "5.5 mg/.122g"}], "application_number": "NDA205488", "marketing_category": "NDA", "marketing_start_date": "20200508", "listing_expiration_date": "20261231"}